8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.23%
Negative revenue growth while Healthcare median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
4.03%
Gross profit growth of 4.03% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
16.71%
EBIT growth of 16.71% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
10.30%
Operating income growth of 10.30% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
4.09%
Net income growth of 4.09% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
4.08%
EPS growth of 4.08% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
4.08%
Diluted EPS growth of 4.08% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
-0.00%
Share reduction while Healthcare median is 0.05%. Seth Klarman would see a relative advantage if others are diluting.
-0.00%
Diluted share reduction while Healthcare median is 0.00%. Seth Klarman would see an advantage if others are still diluting.
-100.00%
Dividend cuts while Healthcare median is 0.00%. Seth Klarman would see if others maintain or grow payouts, highlighting a relative weakness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.09%
10Y CAGR of 59.09% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
71.44%
5Y CAGR of 71.44% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
36.36%
3Y CAGR of 36.36% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
-100.00%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
155.81%
Net income/share CAGR of 155.81% while Healthcare median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
122.26%
Net income/share CAGR of 122.26% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand mid-term.
61.49%
3Y net income/share CAGR of 61.49% while Healthcare median is zero. Walter Schloss might see a small advantage that can be scaled further.
198.97%
Equity/share CAGR of 198.97% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
124.19%
5Y equity/share CAGR of 124.19% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
57.00%
3Y equity/share CAGR of 57.00% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
-100.00%
Dividend declines over 10 years while Healthcare median is 0.00%. Seth Klarman would see a relative disadvantage if peers consistently raised payouts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.00%
AR shrinking while Healthcare median grows. Seth Klarman sees potential advantage unless it signals declining demand.
0.29%
Inventory growth of 0.29% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
-1.54%
Assets shrink while Healthcare median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
4.33%
BV/share growth of 4.33% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-44.81%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
89.49%
SG&A growth of 89.49% while Healthcare median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.